|
|
||||||||
1 Division of Gastrointestinal and Liver Disease and the Research Center for Liver Diseases, University of Southern California Keck School of Medicine, Los Angeles, California 90033; and 2 Department of Cell Biology and Anatomy, University of Arizona, Tucson Arizona 85724
Mechanisms leading to the obstruction of the microcirculation in sinusoidal obstruction syndrome (SOS) have been unclear. Because this occurs at the onset of disease, this is a potential key target for therapeutic intervention. Rats were treated with monocrotaline with or without continuous intraportal infusion of glutathione and were studied at 0.5, 1, 2, 4, 6, and 10 days after monocrotaline treatment with the use of in vivo microscopy and transmission electron microscopy. Sinusoidal perfusion decreased from days 1 through 10 with a nadir on day 4. At 12 h, numerous swollen sinusoidal endothelial cells (SECs) were observed. Subsequently, red blood cells penetrated into the space of Disse through gaps between and through swollen SEC and dissected the sinusoidal lining away from the parenchymal cells. Sinusoidal blood flow was obstructed by an embolism of aggregates of sinusoidal lining cells, red blood cells, and adherent monocytes. All changes were prevented by glutathione infusion, notably the initial swelling of SEC. SOS is initiated by changes in SEC. Microcirculatory obstruction is due to dissection of the sinusoidal lining, followed by embolization of the sinusoid by sinusoidal lining cells, compounded by aggregates of monocytes adherent in the sinusoids. Glutathione prevents SOS by preserving an intact sinusoidal barrier.
endothelium; hepatitis; toxic; glutathione; pyrrolizidine alkaloid
This article has been cited by other articles:
![]() |
A.-L. Berg, G. Bottcher, K. Andersson, E. Carlsson, A.-K. Lindstrom, R. Huby, H. Hakansson, I. Skanberg-Wilhelmsson, and H. Hellmold Early Stellate Cell Activation and Veno-occlusive-disease (VOD)-like Hepatotoxicity in Dogs Treated with AR-H047108, an Imidazopyridine Proton Pump Inhibitor Toxicol Pathol, July 1, 2008; 36(5): 727 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Aird Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds Circ. Res., February 2, 2007; 100(2): 174 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ito, E. R. Abril, N. W. Bethea, M. K. McCuskey, C. Cover, H. Jaeschke, and R. S. McCuskey Mechanisms and pathophysiological implications of sinusoidal endothelial cell gap formation following treatment with galactosamine/endotoxin in mice Am J Physiol Gastrointest Liver Physiol, August 1, 2006; 291(2): G211 - G218. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ito, E. R. Abril, N. W. Bethea, and R. S. McCuskey Inhibition of Matrix Metalloproteinases Minimizes Hepatic Microvascular Injury in Response to Acetaminophen in Mice Toxicol. Sci., January 1, 2005; 83(1): 190 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. M. Hanumegowda, B. L. Copple, M. Shibuya, E. Malle, P. E. Ganey, and R. A. Roth Basement Membrane and Matrix Metalloproteinases in Monocrotaline-Induced Liver Injury Toxicol. Sci., November 1, 2003; 76(1): 237 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wadleigh, P. G. Richardson, D. Zahrieh, S. J. Lee, C. Cutler, V. Ho, E. P. Alyea, J. H. Antin, R. M. Stone, R. J. Soiffer, et al. Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation Blood, September 1, 2003; 102(5): 1578 - 1582. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |